naloxone.

A. As agency funding and agency supplies of naloxone permit, an opioid treatment center agency operating a federally certified program to dispense methadone or other narcotic replacement as part of a detoxification treatment or maintenance treatment shall provide each patient it treats with:

(1)     opioid overdose education that:

(a) conforms to department of health or federal substance abuse and mental health services administration guidelines for opioid overdose education;

(b) explains the causes of an opioid overdose;

(c) instructs when and how to administer in accordance with medical best practices: 1) life-saving rescue techniques; and 2) an opioid antagonist; and

(d) explains how to contact appropriate emergency medical services;

(2)     two doses of naloxone in either a generic form or in a form approved by the federal food and drug administration; and

(3)     a prescription for naloxone.

B. As used in this section, “naloxone” means naloxone hydrochloride, which is an opioid antagonist for the treatment of opioid overdose.